1933 Industries Inc.
1933 Industries Inc.
Your view on TGIF.CN
Overview
What the company does, where it operates, and who runs it.
About 1933 Industries Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Brian Farrell
- Headquarters
- CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Brian Farrell
- Headquarters
- CA
1933 Industries Inc., a cannabis company, engages in the cultivation and production of cannabis products in the United States and Canada. The company produces, packages, and markets of cannabidiol (CBD)-infused products. It operates in the medical and recreational cannabis sectors.
The company also offers CBD infused products, such as tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brands. In addition, it provides cannabis flowers and concentrates.
The company offers CBD infused products through retail dispensaries, retail outlets, and e-commerce platform. 1933 Industries Inc. was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. The company is headquartered in Vancouver, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for 1933 Industries Inc., and the rating behind it. TGIF.CN last traded at C$0.01, 3.1× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for 1933 Industries Inc.. Starting points for 1933 Industries Inc.: P/E 3.1, beta 1.84 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for 1933 Industries Inc.. 1933 Industries Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for 1933 Industries Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for 1933 Industries Inc.. 1933 Industries Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
1933 Industries Inc. valued side by side against its closest peers. 1933 Industries Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold 1933 Industries Inc., and how their positions are changing. At a C$5.0M market value, institutional positions materially move 1933 Industries Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by 1933 Industries Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming 1933 Industries Inc.. 1933 Industries Inc. is a C$5.0M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming 1933 Industries Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for 1933 Industries Inc.. Coverage tracks 1933 Industries Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.